Document:

Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This Securities
Purchase Agreement (this “Agreement”) is dated as of December 24, 2018 (the “date of this Agreement”), by and
among QHY Group, a Nevada corporation (the “Company”), and the investor Mr. Hou Zhigang (RIM,
Passport No. EA3667934) (the “Investor”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to exemptions from registration under the Securities
Act (as defined below), the Company desires to issue and sell to the Investor, and the Investor desires to purchase from the Company,
shares of the Company’s Common Stock (as defined below), as more fully described in this Agreement.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

 

ARTICLE
1.

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Section 1.1:

 

“Action”
as to any Person, means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a
deposition) or investigation pending or threatened in writing against or affecting such Person, any of such Person’s Subsidiaries
or any of such Person’s or such Subsidiaries’ respective properties, before or by any court, arbitrator, governmental or administrative
agency, regulatory authority (federal, state, county, local or foreign), stock market, stock exchange or trading facility.

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is
under common control with a Person, as such terms are used in and construed under Rule 144.

 

“Agreement” has the meaning set forth in the preamble to this Agreement.

 

“Available
Undersubscription Amount” has the meaning set forth in Section 4.11(c).

 

“Basic Amount” has the meaning
set forth in Section 4.11(b).

 

“Business
Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions
in the State of New York or State of Nevada are authorized or required by law or other governmental action to close.

 

“Closing”
means the closing of the purchase and sale of the Shares pursuant to Article

 

     

     

    

 

“Closing
Date” means the Business Day on which all of the conditions set forth in Sections 5.1 and 5.2 hereof are satisfied, or
such other date as the parties may agree.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such common stock
may hereafter be reclassified or for which it may be exchanged as a class.

 

“Company”
has the meaning set forth in the recitals to this Agreement.

 

“Company
Deliverables” has the meaning set forth in Section 2.2(a).

 

“Company
Entities” means the Company and all existing Subsidiaries of any such entity and any other entities which hereafter become
Subsidiaries of any such entity.

 

“Common
Stock Equivalents” means any securities of the Company or any Subsidiary which entitle the holder thereof to acquire
Common Stock at any time, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument
that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or
other securities that entitle the holder to receive, directly or indirectly, Common Stock.

 

“Company
NY Counsel” means Mandelbaum Salsburg P.C., having an address at 1270 Avenue of the Americas, Suite 1808, New York, NY
10020.

 

“Disclosure
Materials” has the meaning set forth in Section 3.1(h).

 

“Evaluation
Date” has the meaning set forth in Section 3.1(s).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Existing
Company Entities” means the Company and its respective Subsidiaries.

 

“GAAP” means U.S. generally accepted accounting principles.

 

“Intellectual
Property Rights” has the meaning set forth in Section 3.1(p).

 

“Investment Amount”
means, with respect to the Investor, Three hundred and forty five thousand American Dollars (USD $345,000).

 

“Investor”
has the meaning set forth in the preamble.

 

“Investor
Deliverables” has the meaning set forth in Section 2.2(b).

 

    2

     

    

 

“Investor
Party” has the meaning set forth in Section 4.6.

 

“Lien”
means any lien, charge, encumbrance, security interest, right of first refusal, right of participation or other restrictions of
any kind.

 

“Losses”
has the meaning set forth in Section 4.6.

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material and adverse effect on the results of operations, assets, properties, prospects, business or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material and adverse impairment to
the Company’s ability to perform on a timely basis its obligations under any Transaction Document.

 

“Money
Laundering Laws” has the meaning set forth in Section 3.1(ee).

 

“New
York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Notice
of Acceptance” has the meaning set forth in Section 4.11(c).

 

“Offer” has the meaning set forth in Section 4.11(b).

 

“Offer
Notice” has the meaning set forth in Section 4.11(b).

 

“Offer
Period” has the meaning set forth in Section 4.11(c).

 

“Offered
Securities” has the meaning set forth in Section 4.11(b).

 

“OFAC” has the meaning set forth in Section 3.1(dd).

 

“Outside
Date” means the fifteenth calendar day (if such calendar day is a Trading Day and if not, then the first Trading Day
following such fifteenth calendar day) following the date of this Agreement.

 

“Per Share Purchase Price”
equals 0.505 USD per Share, and at the price, the Company shall offer, and the Investor shall subscribe 683,168 Offered Securities
of the Company.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

    3

     

    

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or, to the knowledge of the Company, threatened.

 

“Refused
Securities” has the meaning set forth in Section 4.11(d).

 

“Registrable
Securities” shall mean the Shares.

 

“Responding
Investor” has the meaning set forth in Section 4.11(a).

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC
Reports” has the meaning set forth in Section 3.1(h).

 

“Securities Act” means the Securities Act of 1933,
as amended.

 

“Shares”
means the shares of Common Stock being issued and sold to the Investor by the Company hereunder.

 

“Short
Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO
under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps
and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or
foreign regulated brokers.

 

“Subsequent
Placement” has the meaning set forth in Section 4.11(a).

 

“Subsequent Placement Agreement” has the meaning
set forth in Section 4.11(f).

 

“Subsidiary”
of any Person means any “subsidiary” as defined in Rule 1-02(x) of the Regulation S-X promulgated by the Commission
under the Exchange Act of such Person. Notwithstanding anything to the contrary set forth in any Transaction Document, QHY Water
Solutions International Corp (the “QHY Water Solutions”), PBG Water Solutions International Inc. (the “PBG Water
Solutions”) and their respective subsidiaries are each considered a Subsidiary of the Company.

 

“Trading
Day” means (i) a day on which the Common Stock is traded on a Trading Market or (ii) if the Common Stock is not listed
or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink
Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event
that the Common Stock is not listed or quoted as set forth in (i) or (ii) hereof, then Trading Day shall mean a Business Day.

 

    4

     

    

 

“Trading
Market” means whichever of the New York Stock Exchange, NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global
Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date
in question.

 

“Transaction
Documents” means this Agreement and any other documents or agreements executed in connection with the transactions contemplated
hereunder.

 

“Transfer
Agent” means Globex Transfer, LLC, the current transfer agent of the Company with a mailing address of 780 Deltona Blvd.,
Suite 202, Deltona, FL 32725 and a facsimile number of (813) 344-4490, and any successor transfer agent of the Company.

 

“Trigger
Date” has the meaning set forth in Section 4.11(a).

 

“Undersubscription Amount” has the meaning set forth
in Section 4.11(a).

 

ARTICLE
2.

PURCHASE
AND SALE

 

2.1 Closing. Subject
to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and sell to the Investor, and
the Investor shall purchase from the Company, the Shares representing such Investor’s Investment Amount, calculated as
the quotient of such Investor’s Investment Amount divided by the Per Share Purchase Price. The Closing shall take
place at the offices of Mandelbaum Salsburg P.C. on the Closing Date or at such other location or time as the parties may
agree.

 

2.2
Closing Deliveries. (a) At the Closing, the Company shall deliver or cause to be delivered to the Investor the
following (the “Company Deliverables”):

 

(i) a
single certificate, dated the Closing Date, issued to the Investor, respectively, representing that number of aggregate Shares
to be issued and sold at Closing to such Investor, determined under Section 2.1, registered in the name of such Investor;

 

(ii) the
legal opinion of Company NY Counsel, in agreed form, addressed to the Investor;

 

(b) By
the Closing, the Investor shall deliver or cause to be delivered the agreements specified in Section 5.2(d), each duly signed
by such Investor (collectively, the “Investor Deliverables”).

 

(c) Within
two (2) Trading Days following the date of this Agreement, the Investor shall deliver in accordance with Section 6.7(b) for deposit
and disbursement its Investment Amount, in American Dollars or Chinese Yuan and in immediately available funds, by wire transfer
to an account designated in writing by the Company for such purpose.

 

    5

     

    

 

ARTICLE
3.

REPRESENTATIONS
AND WARRANTIES

 

3.1 Representations
and Warranties of the Company. The Company hereby makes the following representations and warranties to the Investor:

 

(a)
Subsidiaries. None of the Existing Company Entities have any direct or indirect Subsidiaries other than as disclosed in
Schedule 3.1(a) hereto. Except as disclosed in Schedule 3.1(a) hereto, (i) the Company owns, directly or indirectly,
all of the capital stock of each other Existing Company Entity, and each other Existing Company Entity alone or together with
other Existing Company Entities owns, directly or indirectly, all of the capital stock of its respective Subsidiaries, in each
case free and clear of any and all Liens, and (ii) all the issued and outstanding shares of capital stock of each Existing Company
Entity and each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights.

 

(b)
Organization and Oualification. Each Existing Company Entity is duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite
power and authority to own and use its respective properties and assets and to carry on its respective business as currently conducted.
No Existing Company Entity is in violation of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each Existing Company Entity is duly qualified to conduct its respective
businesses and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect.

 

(c)
Authorization; Enforcement. Each Existing Company Entity which is or is to become party to any Transaction Document has
the requisite corporate and other power and authority to enter into and to consummate the transactions contemplated by each such
Transaction Document to which it is a party and otherwise to carry out its obligations thereunder. The execution and delivery
of the Transaction Documents by each Existing Company Entity to be party thereto and the consummation by each of them of the transactions
contemplated thereby have been duly authorized by all necessary action on the part of such Existing Company Entity, and no further
action is required by any of them in connection with such authorization. Each Transaction Document has been (or upon delivery
will have been) duly executed by the Company and each other Existing Company Entity required to execute the same and each Subsidiary
(to the extent any of them is a party thereto) and, when delivered in accordance with the terms hereof, will constitute the valid
and binding obligation of the Company, such Existing Company Entity, and such Subsidiary, enforceable against the Company, the
Existing Company Entity, and the Subsidiary, as the case may be, each in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting
generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

    6

     

    

 

(d)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company, and each other Existing
Company Entity and Subsidiary and the consummation by the Company, and such other Existing Company Entities and Subsidiaries,
of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s,
such Existing Company Entity’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational
or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing an Existing Company Entity
or Subsidiary debt or otherwise) or other understanding to which any Existing Company Entity or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any United States court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(e)
Filings, Consents and Approvals. No Existing Company Entity is required to obtain any consent, waiver, authorization or
order of, give any notice to, or make any filing or registration with, any United States or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the Company, and each Subsidiary,
to the extent such Subsidiary is a party thereto, of the Transaction Documents, other than (i) the filing with the Commission
of one or more Registration Statements, (ii) filings required by state securities laws, (iii) the filing of a Notice of Sale of
Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) the filings required in accordance with
Section 4.5, (v) filings, consents and approvals required by the rules and regulations of the applicable Trading Market, (vi)
those that have been made or obtained prior to the date of this Agreement, and (vii) other post closing securities filings or
notifications required to be made under federal or state securities laws.

 

(f)
Issuance of the Shares. The Shares have been duly authorized and, when issued and paid for in accordance with the Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens. As of the Closing, the
Company has reserved from its duly authorized capital stock the shares of Common Stock issuable pursuant to this Agreement in
order to issue the Shares.

 

    7

     

    

 

(g)
Capitalization. The number of shares and type of all authorized, issued and outstanding capital stock of the Company, and
all shares of Common Stock reserved for issuance under the Company’s various option and incentive plans, is specified in
Schedule 3.1(g). Except as specified in Schedule 3.1(g), no securities of any Existing Company Entity are entitled
to preemptive or similar rights, and no Person has any right of first refusal, preemptive right, right of participation, or any
similar right to participate in the transactions contemplated by the Transaction Documents. Except as specified in Schedule
3.1(g), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to issue additional shares of Common Stock, or securities or rights convertible or exchangeable
into shares of Common Stock. The issue and sale of the Shares hereunder will not, immediately or with the passage of time, obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Investor) and
will not result in a right of any holder of Company or Subsidiary securities to adjust the exercise, conversion, exchange or reset
price under such securities. Except as set forth in Schedule 3.1(g), no Existing Company Entity has issued any capital
stock in a private placement transaction.

 

(h)
SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act
and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof (or
such shorter period as the Company was required by law to file such reports), (the foregoing materials being collectively referred
to herein as the “SEC Reports” and, together with Appendix B hereto and the schedules to this Agreement, the
“Disclosure Materials”) on a timely basis or has timely filed a valid extension of such time of filing and has filed
any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in
all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The financial statements of the Company and each Subsidiary included in the SEC Reports
comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a
consistent basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto,
and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.

 

(i)
Press Releases. To the knowledge of the Company, the press releases disseminated by the Company during the twelve months
preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made and when made, not misleading.

 

Material
Changes. Except as specified on Schedule 3.1(j) or in the Disclosure Materials, since December 31, 2017 (i) there
has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material
Adverse Effect, (ii) no Existing Company Entity has incurred any liabilities (contingent or otherwise) other than (A) trade
payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent with past practice,
and (B) liabilities not in excess of $100,000 in the aggregate not required to be reflected in the Company’s or its
Subsidiaries’ financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission,
(iii) no Existing Company Entity has altered its method of accounting or the identity of its auditors, (iv) no Existing
Company Entity has declared or made any dividend or distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) no Existing Company Entity has
issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.
The Company does not have pending before the Commission any request for confidential treatment of information.

 

    8

     

    

 

(k) Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction
Documents or the Shares or (ii) if there were an unfavorable decision, individually or in the aggregate, result in a loss or liability
in an amount in excess of $10,000 or have or reasonably be expected to result in a Material Adverse Effect. No Existing Company
Entity, nor any director or officer thereof (in his or her capacity as such), is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, except as
specifically disclosed in the SEC Reports. There has not been, and to the knowledge of the Company, there is not pending any investigation
by the Commission involving any Existing Company Entity or any of their respective current or former directors or officers (in
his or her capacity as such). The Commission has not issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(l)
Labor Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any
of the employees of any Existing Company Entity. No Existing Company Entity has any employment or labor contracts, agreements
or other understandings with any Person.

 

(m) Indebtedness:
Compliance. Except as disclosed on Schedule 3.1(m), no Existing Company Entity is a party to any indenture, debt, capital
lease obligations, mortgage, loan or credit agreement by which it or any of its properties is bound. No Existing Company Entity
is (i) in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time
or both, would result in a default by such entity under), nor has any Existing Company Entity received notice of a claim that
it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) in violation of any order of any court, arbitrator or governmental body, or (iii) in violation of any statute, rule or regulation
of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental
protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as
could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. The Company
is in compliance with all effective requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
thereunder that are applicable to it, except where such noncompliance could not have or reasonably be expected to result in a
Material Adverse Effect.

 

    9

     

    

 

(n)
Regulatory Permits. The Existing Company Entities possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC
Reports, except where the failure to possess such permits could not, individually or in the aggregate, have or reasonably be expected
to result in a Material Adverse Effect, and no Existing Company Entity has received any notice of proceedings relating to the
revocation or modification of any such permits.

 

(o)
Title to Assets. There is no real property that is material to the respective businesses of the Existing Company Entities,
except as disclosed in the Disclosure Materials. The Existing Entities have good and marketable title in all personal property
owned by them that is material to their respective businesses, in each case free and clear of all Liens, except for Liens as do
not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of
such property by such Existing Company Entity. Any real property and facilities held under lease by any Existing Company Entity
are held by them under valid, subsisting and enforceable leases of which such Existing Company Entity is in compliance, except
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(p)
Patents and Trademarks. Set forth on Schedule 3.1(p) is a list of patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar rights that the Existing Company Entities own
or have the rights to use (collectively, the “Intellectual Property Rights”). The Intellectual Property Rights constitute
all of the patents, patent applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses
and other similar rights that are necessary and material to the business of the Existing Company Entities in connection with their
respective businesses as described in the Disclosure Materials. No Existing Company Entity has received a written notice that
the Intellectual Property Rights used by any of them violates or infringes upon the rights of any Person. Except as otherwise
disclosed in the Disclosure Materials, to the knowledge of the Existing Company Entities, all such Intellectual Property Rights
are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. To the knowledge
of the Existing Company Entities, no former or current employee, no former or current consultant, and no third-party joint developer
of any Existing Company Entity has any Intellectual Property Rights that are necessary and material to the business of the Existing
Company Entities made, developed, conceived, created or written by the aforesaid employee, consultant or third-party joint developer
during the period of his or her retention by, or joint venture with, such Existing Company Entity which has been asserted against
any Existing Company Entity. The Intellectual Property Rights and the owner thereof or agreement through which they are licensed
to any of the Existing Company Entities are set forth in the Disclosure Materials.

 

(q)
Insurance. Each Existing Company Entity is insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses it is engaged and in the country in which the Existing
Company Entities operate. The Company has no reason to believe that it or any Existing Company Entity will not be able to renew
its existing respective insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business on terms consistent with market for the Company’s and such other Existing Company
Entity’s respective lines of business.

 

    10

     

    

 

(r)
Transactions With Affiliates and Employees; Customers. Except as set forth in the Disclosure Materials, none of the officers,
directors or 5% or more shareholders of any Existing Company Entity, and, to the knowledge of the Company, none of the employees
of any Existing Company Entity, is presently a party to any transaction with any Existing Company Entity (other than for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any
such Person or, to the knowledge of the Company, any entity in which any officer, director, or such employee or 5% or more shareholder
has a substantial interest or is an officer, director, trustee or partner. None of the Existing Company Entities owes any money
or other compensation to any of their respective officers or directors or shareholders, except to extent of contracts and ordinary
course compensation arrangements specified in Schedule 3.1(r). No material customer of any Existing Company Entity has
indicated their intention to diminish their relationship with such Existing Company Entity and no Existing Company Entity has
any knowledge from which it could reasonably conclude that any such customer relationship may be adversely affected.

 

(s)
Internal Accounting Controls. The Existing Company Entities maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization,
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company is establishing disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company Entities and designed such disclosure controls and procedures to ensure that
material information relating to the Company Entities is made known to the certifying officers by others within those entities,
particularly during the period in which the Company’s Form 10-K or 10-Q, as the case may be, is being prepared. The Company’s
certifying officers have evaluated the effectiveness of the Company’s controls and procedures in accordance with Item 307
of Regulation S-K under the Exchange Act for the Company’s most recently ended fiscal quarter or fiscal year-end (such date,
the “Evaluation Date”). The Company presented in its most recently filed Form 10-K or Form 10-Q the conclusions of
the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the
Evaluation Date.

 

(t)
Solvency. Based on the financial condition of the Company, including the Existing Company Entities, as of the Closing Date
(and assuming that the Closing shall have occurred), (i) each Existing Company Entity’s assets do not constitute unreasonably
small capital to carry on their respective business for the current fiscal year as now conducted and as proposed to be conducted
including its capital needs taking into account the particular capital requirements of the business conducted by such Existing
Company Entity, and projected capital requirements and capital availability thereof and (ii) the current cash flow of such Existing
Company Entity, together with the proceeds such Existing Company Entities would receive, were they to liquidate all of their respective
assets, after taking into account all anticipated uses of the cash, would not be sufficient to pay all amounts on or in respect
of its debt when such amounts are required to be paid. The Existing Company Entities intend to incur debts beyond the current
indebtedness so to finance their operation until they generate sufficient revenues.

 

    11

     

    

 

(u)
Certain Fees. Except as described in Schedule 3.1(u), no brokerage or finder’s fees or commissions are or
will be payable by any Existing Company Entity to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by this Agreement. The Investor shall have no obligation
with respect to any fees or with respect to any claims (other than such fees or commissions owed by an Investor pursuant to written
agreements executed by such Investor which fees or commissions shall be the sole responsibility of such Investor) made by or on
behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by this Agreement.

 

(v)
Certain Registration Matters. Assuming the accuracy of the Investor’s representations and warranties set forth in
Sections 3.2(b)-(e), no registration under the Securities Act is required for the offer and sale of the Shares by the Company
to the Investor under the Transaction Documents. The Company is eligible to register its Common Stock for resale by the Investor
under Form S-1 promulgated under the Securities Act. Except as specified in Schedule 3.1(v), no Existing Company Entity
has granted or agreed to grant to any Person other than the Investor any rights (including “piggyback” registration
rights) to have any securities of the Company registered with the Commission or any other governmental authority that have not
been satisfied.

 

(w)
Listing and Maintenance Requirements. Except as specified in the SEC Reports, the Company has not, in the one year preceding
the date hereof, received notice from any Trading Market to the effect that the Company is not in compliance with the listing
or maintenance requirements thereof. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with the listing and maintenance requirements for continued listing of the Common Stock on the Trading Market
on which the Common Stock is currently listed or quoted. The issuance and sale of the Shares under the Transaction Documents does
not contravene the rules and regulations of the Trading Market on which the Common Stock is currently listed or quoted, and no
approval of the stockholders of the Company thereunder is required for the Company to issue and deliver to the Investor the Shares
as contemplated by the Transaction Documents.

 

(x)
Investment Company. The Company is not, and is not an Affiliate of, and immediately following the Closing will not have
become, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

(y)
Application of Takeover Protections. The Company has taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other
similar anti-takeover provision under the Company’s Certificate of Incorporation (or similar charter documents) or the laws
of its state of incorporation that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling
their obligations or exercising their rights under the Transaction Documents, including, without limitation, the Company’s
issuance of the Shares and the Investor’s ownership of the Shares.

 

    12

     

    

 

(z) No
Additional Agreements. No Existing Company Entity has any agreement or understanding with any Investor with respect
to the transactions contemplated by the Transaction Documents other than as specified in the Transaction
Documents.

 

(aa) Consultation
with Auditors. The Company has consulted its independent auditors concerning the accounting treatment of the transactions
contemplated by the Transaction Documents, and in connection therewith has furnished such auditors complete copies of the
Transaction Documents.

 

(bb) Foreign
Corrupt Practices Act. No Existing Company Entity, nor to the knowledge of the Company, any agent or other person
acting on behalf of any Existing Company Entity, has, directly or indirectly, (i) used any funds, or will use any proceeds
from the sale of the Shares, for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign
or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or
to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company or any such Existing Company Entity (or made by any Person acting on their behalf of which
the Company is aware) which is in violation of law, or (iv) has violated in any material respect any provision of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.

 

(cc)
PFIC. The Company is not, and does not intend to become a “passive foreign investment company” within the meaning
of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

(dd) OFAC. No
Existing Company Entity nor, to the knowledge of the Company, any director, officer, agent, employee, Affiliate or Person
acting on behalf of any Existing Company Entity, is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or
indirectly use the proceeds of the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any
Subsidiary, joint venture partner or other Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan,
Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently
subject to any U.S. sanctions administered by OFAC.

 

(ee) Money
Laundering Laws. The operations of each Existing Company Entity are and have been conducted at all times in
compliance with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any applicable governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving any Existing Company Entity with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company, threatened.

 

    13

     

    

 

(ft) Disclosure. Neither
any Company Entity nor any Person acting on its behalf has provided any Investor or its respective agents or counsel with any
information that any Company Entity believes constitutes material, non-public information concerning the Company, the
Subsidiaries or their respective businesses, except insofar as the existence and terms of the proposed
transactions contemplated hereunder may constitute such information. The Company understands and confirms that the Investor
will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All
disclosure provided to the Investor regarding the Company Entities and their respective businesses and the transactions
contemplated hereby, furnished by or on behalf of the Company Entities (including their respective representations and
warranties set forth in this Agreement and the disclosure set forth in any diligence report or business plan provided by any
Company Entity or any Person acting on such Company Entity’s behalf) are true and correct and do not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading.

  

3.2. Representations
and Warranties of the Investor. The Investor hereby, for itself and for no other Investor, represents and warrants to the
Company as follows:

 

(a)
Organization: Authority. Such Investor is an entity duly organized, validly existing and in good standing under the laws
of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents to which it is a party or a signatory and otherwise to carry out its
obligations thereunder. The execution, delivery and performance by such Investor of the transactions contemplated by this Agreement
has been duly authorized by all necessary corporate or, if such Investor is not a corporation, such partnership, limited liability
company or other applicable like action, on the part of such Investor. Each Transaction Document executed by such Investor has
been duly executed by such Investor, and when delivered by such Investor in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Investor, enforceable against it in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general
application.

 

(b)
Investment Intent. Such Investor is acquiring the Shares as principal for its own account and not with a view to or for
distributing or reselling such Shares or any part thereof, without prejudice, however, to such Investor’s right at all times
to sell or otherwise dispose of all or any part of such Shares in compliance with applicable federal and state securities laws.
Subject to the immediately preceding sentence, nothing contained herein shall be deemed a representation or warranty by such Investor
to hold the Shares for any period of time. Such Investor is acquiring the Shares hereunder in the ordinary course of its business.
Such Investor does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Shares.

 

(c)
Investor Status. At the time such Investor was offered the Shares, it is not a registered broker-dealer under Section 15
of the Exchange Act. Such Investor has such experience in business and financial matters that it is capable of evaluating the
merits and risks of an investment in the Shares. Such Investor acknowledges that an investment in the Shares is speculative and
involves a high degree of risk.

 

    14

     

    

 

(d)
General Solicitation. Such Investor is not purchasing the Shares as a result of any advertisement, article, notice, meeting,
or other communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(e)
Access to Information. Such Investor acknowledges that it has reviewed the Disclosure Materials and has been afforded (i)
the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access
to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business,
properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such
additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
an informed investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted by
or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely
on the truth, accuracy and completeness of the Disclosure Materials and the Existing Company Entities’ representations and
warranties contained in the Transaction Documents.

 

(f)
Certain Trading Activities. Such Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with such Investor, engaged in any transactions in the securities of the Company (including, without limitations,
any Short Sales involving the Company’s securities) since the earlier to occur of (1) the time that such Investor was first
contacted by the Company regarding an investment in the Company and (2) the 30th day prior to the date of this Agreement. Such
Investor covenants that neither it nor any Person acting on its behalf or pursuant to any understanding with it will engage in
any transactions in the securities of the Company (including Short Sales) prior to the time that the transactions contemplated
by this Agreement are publicly disclosed.

 

(g)
Independent Investment Decision. Such Investor has independently evaluated the merits of its decision to purchase the Shares
pursuant to the Transaction Documents, and such Investor confirms that it has not relied on the advice of any other Investor’s
business and/or legal counsel in making such decision. Such Investor has not relied on the business or legal advice of any of
its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of such Persons has made
any representations or warranties to such Investor in connection with the transactions contemplated by the Transaction Documents.

 

(h)
Rule 144. Such Investor understands that the Securities must be held indefinitely unless such Securities are registered
under the Securities Act or an exemption from registration is available. Such Investor acknowledges that it is familiar with Rule
144 and that such Investor has been advised that Rule 144 permits resales only under certain circumstances. Such Investor understands
that to the extent that Rule 144 is not available, such Investor will be unable to sell any Securities without either registration
under the Securities Act or the existence of another exemption from such registration requirement.

 

    15

     

    

 

(i)
General. Such Investor understands that the Securities are being offered and sold in reliance on a transactional exemption
from the registration requirements of federal and state securities laws and the Company is relying upon the truth and accuracy
of the representations, warranties, agreements, acknowledgments and understandings of such Investor set forth herein in order
to determine the applicability of such exemptions and the suitability of such Investor to acquire the Securities. Such Investor
understands that no United States federal or state agency or any government or governmental agency has passed upon or made any
recommendation or endorsement of the Securities.

 

The
Existing Company Entities acknowledge and agree that no Investor has made or makes any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in this Section 3.2.

 

ARTICLE
4.

OTHER
AGREEMENTS OF THE PARTIES

 

4.1. Transferability:
Certificate. (a) Shares may only be disposed of in compliance with state and federal securities laws. In connection with any
transfer of the Shares other than pursuant to an effective registration statement, to the Company, to an Affiliate of an Investor
or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to
the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities
Act.

 

(b) Certificates
evidencing Securities will contain the following legend:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

 

The
Company acknowledges and agrees that an Investor may from time to time pledge, and/or grant a security interest in some or
all of the Securities pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required
under the terms of such agreement or account, such Investor may transfer pledged or secured Shares to the pledgees or secured
parties. Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion of legal
counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge but such legal but Such
legal opinion may be required in connection with a subsequent transfer following default by the Investor transferee of the
pledge. No notice shall be required of such pledge. At the appropriate Investor’s expense, the Company will execute and
deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a
pledge or transfer thereof including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of
the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder. Any Securities subject to a pledge or security interest as contemplated by this Section 4.1(b) shall
continue to bear the legend set forth in this Section 4.1(b) and be subject to the restrictions on transfer set forth in
Section 4.1(a).

 

    16

     

    

 

4.2 Furnishing
of Information. As long as any Investor owns any Securities, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the
date hereof pursuant to the Exchange Act. As long as any Investor owns Securities, if the Company is not required to
file reports pursuant to such laws, it will prepare and furnish to the Investor and make publicly available in accordance
with Rule 144(c) such information as is required for the Investor to sell the Securities under Rule 144. The Company further
covenants that it will take such further action as any holder of Securities may reasonably request, all to the extent
required from time to time to enable such Person to sell the Securities without registration under the Securities Act within
the limitation of the exemptions provided by Rule 144.

 

4.3 Integration. The
Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or
solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that
would be integrated with the offer or sale of the Shares in a manner that would require the registration under the
Securities Act of the sale of the Shares to the Investor, or that would be integrated with the offer or sale of the Shares
for purposes of the rules and regulations of any Trading Market in a manner that would require stockholder approval of the
sale of the Shares to the Investor.

 

4.4 Subsequent
Registrations. The Company may not file any registration statement with the Commission with respect to any securities of
the Company prior to the time that all Registrable Shares are registered pursuant to one or more effective Registration
Statement(s), and the prospectuses forming a portion of such Registration Statement(s) is available for the resale of all
Registrable Shares.

 

4.5 Securities
Laws Disclosure: Publicity. By 5:00 p.m. (New York time) on the Trading Day following the Closing Date, (a) the Company
shall issue a press release, disclosing the transactions contemplated by the Transaction Documents and the Closing and (b)
the Company will file a Form 8-K disclosing the material terms of the Transaction Documents (and attach as exhibits
thereto all existing Transaction Documents) and the Closing. The Company covenants that following such disclosure, the
Investor shall no longer be in possession of any material, non-public information with respect to any of the Existing Company
Entities. In addition, the Company will make such other filings and notices in the manner and time required by the Commission
and the Trading Market on which the Common Stock is listed. Notwithstanding the foregoing, the Company shall not publicly
disclose the name of any Investor, or include the name of any Investor in any filing with the Commission (other than the
Registration Statement
and any exhibits to filings made in respect of this transaction in accordance with periodic filing requirements under the Exchange
Act) or any regulatory agency or Trading Market, without the prior written consent of such Investor, except to the extent such
disclosure is required by law or Trading Market regulations.

 

    17

     

    

  

4.6 Indemnification
of Investor. The Company Entities will jointly and severally indemnify and hold the Investor and their
directors, officers, shareholders, partners, employees and agents (each, an “Investor Party”) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation in respect thereof
(collectively, “Losses”) that any such Investor Party may suffer or incur as a result of or relating to any
misrepresentation, breach or inaccuracy of any representation, warranty, covenant or agreement made by any of the Company
Entities in any Transaction Document. In addition to the indemnity contained herein, the Company will reimburse the Investor
Party for its reasonable legal and other expenses (including the cost of any investigation, preparation and travel in
connection therewith) incurred in connection therewith, as such expenses are incurred.

 

4.7 Non-Public
Information. The Company covenants and agrees that neither it, any Company Entity nor any other Person acting on its or
their behalf will provide any Investor or its agents or counsel with any information that the Company believes
constitutes material non-public information, unless prior thereto such Investor shall have executed a written agreement
regarding the confidentiality and use of such information. The Company understands and confirms that the Investor shall be
relying on the foregoing representations in effecting transactions in securities of the Company.

 

4.8 Listing
of Shares. The Company agrees, (i) if the Company applies to have the Common Stock traded on any other Trading Market, it
will include in such application the Shares, and will take such other action as is necessary or desirable to cause the
Shares to be listed on such other Trading Market as promptly as possible, and (ii) the Company will take all action
reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all
material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading
Market.

 

4.9 Use
of Proceeds. The Company will use the net proceeds from the sale of the Shares hereunder for working capital of
the Company and its subsidiaries.

 

4.10 Further
Assurances. The Company will, and will cause all of the Company Entities and their management to, use their best efforts
to satisfy all of the closing conditions under Section 5.1, and will not take any action which could frustrate or delay the
satisfaction of such conditions.

 

    18

     

    

 

4.11 Right
of First Refusal. (a) From the date hereof until the one year anniversary of the Closing Date (plus one additional day
for each Trading Day following the Effective Date of any Registration Statement during which either (1) the Registration
Statement is not effective or (2) the prospectus forming a portion of the Registration Statement is not available for the
resale of all Registrable Securities) (the “Trigger Date”), the Company will not, directly or indirectly, offer,
sell, grant any option to purchase, or otherwise dispose of (or announce any offer, sale, grant or any option to
purchase or other disposition of) any of its equity or equity equivalent securities, including, without limitation, any debt,
preferred stock or other instrument or security that is, at any time during its life and under any circumstances, convertible
into or exchangeable or exercisable for shares of Common Stock or Common Stock Equivalents, or if the Company shall receive
an offer regarding the purchase of the Company’s securities and desires to offer securities consistent with or
otherwise in connection with or in furtherance of such offer (any such offer, sale, grant, disposition or announcement being
referred to as a “Subsequent Placement”) unless the Company shall have first complied with this Section 4.11. If
the Company desires to engage in a Subsequent Placement it shall deliver to each of the Investor a written notice requesting
their written approval to receive nonpublic information regarding the Company. The Investor shall have ten (10) days to
deliver to the Company such approval. Any Investor failing to deliver timely to the Company such written approval, or who
shall have delivered to the Company a written notice withholding such approval, shall be deemed to have waived its rights
under this Section 4.11 with regard to such Subsequent Placement. The Investor who, in response to such request from the
Company, shall have delivered timely to the Company a written approval to receive nonpublic information regarding the Company
(collectively, the “Responding Investor” and each a “Responding Investor”), shall receive a written
notice that the Company desires to engage in a Subsequent Placement specifying the general terms of the offering the Company
desires to make (including, without limitation, all information relating to price, structure and amount of such offering, but
not including the identity of any potential investor therein) and for a period of at least twenty (20) Business Days
after the giving of such notice the Company agrees to negotiate in good faith with the Responding Investor the terms of a
sale of the Company’s securities to the Responding Investor.

 

(b) In
the event that a Subsequent Placement contemplated in the last sentence of Section 4.11(a) shall not have closed by the 30th Business
Day following the delivery to the Responding Investor of the written notice for such Subsequent Placement, and in any event prior
to such Subsequent Placement, the Company shall deliver to the Responding Investor a written notice (the “Offer Notice”)
of any proposed or intended issuance or sale or exchange (the “Offer”) of the securities being offered (the “Offered
Securities”) in a Subsequent Placement, which Offer Notice shall (v) identify and describe the Offered Securities, (x) include
the final form of documents and agreements governing the Subsequent Placement, (y) specify the price and other terms upon which
the Offered Securities are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold
or exchanged, and (z) offer to issue and sell to or exchange with such Investor all of the Offered Securities, allocated among
such Responding Investor (a) based on such Responding Investor’s pro rata portion of the total Investment Amount hereunder attributable
to such Responding Investor (the “Basic Amount”), and (b) with respect to each of the Responding Investor that elects
to purchase its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other Responding
Investor as such Responding Investor shall indicate it will purchase or acquire should the other Responding Investor subscribe
for less than their Basic Amounts (the “Undersubscription Amount”), which process shall be repeated until the Responding
Investor shall have an opportunity to subscribe for any remaining Undersubscription Amount.

 

    19

     

    

 

(c)
To accept an Offer, in whole or in part, such Responding Investor must deliver a written notice to the Company prior to the
end of the fifth Business Day after such Responding Investor’s receipt of the Offer Notice (the “Offer
Period”), setting forth the portion of such Responding Investor’s Basic Amount that such Responding Investor
elects to purchase and, if such Responding Investor shall elect to purchase all of its Basic Amount, the Undersubscription
Amount, if any, that such Responding Investor elects to purchase (in either case, the “Notice of Acceptance”). If
the Basic Amounts subscribed for by all Responding Investor are less than the total of all of the Basic Amounts, then each
Responding Investor who has set forth an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase,
in addition to the Basic Amounts subscribed for, the Undersubscription Amount it has subscribed for; provided,
however, that if the Undersubscription Amounts subscribed for exceed the difference between the total of all the Basic
Amounts and the Basic Amounts subscribed for (the “Available Undersubscription Amount”), each Responding Investor
who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of the Available
Undersubscription Amount as the Basic Amount of such Investor bears to the total Basic Amounts of all Responding Investor
that have subscribed for Undersubscription Amounts, subject to rounding by the Company to the extent its deems
reasonably necessary.

 

(d) The
Company shall have sixty (60) Business Days from the expiration of the Offer Period above to (i) offer, issue, sell or exchange
all or any part of such Offered Securities as to which a Notice of Acceptance has not been given by the Responding Investor (the
“Refused Securities”), but only to the offerees described in the Offer Notice (if so described therein) and only upon
terms and conditions (including, without limitation, unit prices and interest rates) that are not more favorable to the acquiring
person or persons or less favorable to the Company than those set forth in the Offer Notice and (ii) to publicly announce (a)
the execution of such Subsequent Placement Agreement (as defined below), and (b) either (x) the consummation of the transactions
contemplated by such Subsequent Placement Agreement or (y) the termination of such Subsequent Placement Agreement, which shall
be filed with the Commission on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated
therein filed as exhibits thereto. If no disclosure has been made by the Company by the end of the sixty (60) Business Day period
referred to in this subsection (d), the Subsequent Placement shall be deemed to have been abandoned and the Responding Investor
shall no longer be deemed to be in possession of any non-public information with respect to the Company.

 

(e) In
the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the
terms specified in this Section 4.11), then each Responding Investor may, at its sole option and in its sole discretion, reduce
the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than
the number or amount of the Offered Securities that such Responding Investor elected to purchase pursuant to Section 4.11(c) above
multiplied by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually
proposes to issue, sell or exchange (including Offered Securities to be issued or sold to Investor pursuant to Section 4.11(c)
above prior to such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the
event that any Responding Investor so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance,
the Company may not issue, sell or exchange more than the reduced number or amount of the Offered Securities unless and until
such securities have again been offered to the Responding Investor in accordance with Section 4.11(b) above.

 

    20

     

    

 

(f) Upon
the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, the Responding Investor shall
acquire from the Company, and the Company shall issue to the Responding Investor, the number or amount of Offered Securities specified
in the Notices of Acceptance, as reduced pursuant to Section 4.11(e) above if the Responding Investor have so elected, upon the
terms and conditions specified in the Offer. The purchase by the Responding Investor of any Offered Securities is subject in all
cases to the preparation, execution and delivery by the Company and the Responding Investor of a purchase agreement relating to
such Offered Securities substantially the same in form and substance as the agreement disclosed above in Section 4.11(b)(x) and
otherwise reasonably satisfactory to Responding Investor’s counsel (such agreement, the “Subsequent Placement Agreement”).

 

(g) Any
Offered Securities not acquired by the Responding Investor or other persons in accordance with Section 4.11(f) above may not be
issued, sold or exchanged until they are again offered to the Investor under the procedures specified in this Agreement.

 

(h) In
exchange for the Company’s willingness to agree to these procedures, each Responding Investor hereby irrevocably agrees that it
will hold in strict confidence any and all Offer Notices, the information contained therein, and the fact that the Company is
contemplating a Subsequent Placement, until such time as the Company is obligated to make the disclosures required by Section
4.11(d), or unless it notifies the Company in writing that it no longer desires to receive Offer Notices.

 

(i) The
rights contained in this Section 4.11 shall not apply to the issuance and sale by the Company of shares of Common Stock or Common
Stock Equivalents issued as consideration for the acquisition of another company or business in which the shareholders of the
Company do not have an ownership interest, and where the primary purpose is not to raise capital for the Company or Subsidiary,
which acquisition has been approved by the Board of Directors of the Company.

 

ARTICLE
5.

CONDITIONS
PRECEDENT TO CLOSING

 

5.1. Conditions
Precedent to the Obligations of the Investor to Purchase Shares. The obligation of the Investor to acquire Shares at the Closing
is subject to the satisfaction or waiver by such Investor, at or before the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Existing Company Entities contained herein shall
be true and correct in all material respects as of the date when made and as of the Closing as though made on and as of such date;

 

(b)
Performance. The Existing Company Entities shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at
or prior to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents;

 

    21

     

    

 

(d)
Adverse Changes. Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably
could have or result in a Material Adverse Effect or a material adverse change with respect to the Company or the Subsidiaries;

 

(e)
Closing Officer’s Certificate. At the Closing, the Company shall have delivered to the Investor an officer’s
certificate to the effect that each of the conditions specified in Sections 5.1(a) - 5.1(d) is satisfied in all respects;

 

(f)
Company Agreements. The Company shall have delivered or cause to be delivered this Agreement, duly executed by the Company;

 

(g)
Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a); and

 

(h)
Termination. This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

5.2 Conditions
Precedent to the Obligations of the Company to Sell Shares. The obligation of the Company to sell Shares at the Closing is
subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Investor contained herein shall be true and correct
in all material respects as of the date when made and as of the Closing Date as though made on and as of such date;

 

(b)
Performance. The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior
to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents;

 

(d)
Investor Deliverables. The Investor shall have delivered this Agreement; and

 

(e)
Termination. This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

    22

     

    

 

ARTICLE
6.

MISCELLANEOUS

 

6.1
Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of the Transaction Documents. The Company shall pay all stamp and other taxes and duties levied in connection with the sale of
the Shares.

 

6.2
Entire Agreement. The Transaction Documents, together with the Exhibits, Exhibit A and Exhibit B, and Schedules
thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements,
understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.

 

6.3
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via (i) facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the
facsimile number specified in this Section or (ii) electronic mail (i.e., Email) prior to 6:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via (i) facsimile
at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) on a day that is not a Trading Day or
later than 6:30 p.m. (New York City time) on any Trading Day, or (c) the Trading Day following the date of mailing, if sent by
U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required
to be given, if sent by any means other than facsimile or Email transmission. The address for such notices and communications
shall be as follows:

 

	If to the Company: 	QHY Group
	 	1501 Broadway, Suite 1515
	 	New York, NY
	 	Attn.: Mao Xu
	 	 
	With a copy to:	Mandelbaum Salsburg P.C.
	 	1270 Avenue of the Americas, Suite 1808,
	 	New York, NY 10020
	 	Attention: Vincent J. McGill
	 	 
	If to the Investor:	Room 801, unit one, building 10, Guanhuguoji housing estate, No.88 North road of East fourth Ring, Chaoyang District, Beijing City, China 100026
	 	Attention: Mr. Hou Zhigang (IRMO

 

or
such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

    23

     

    

 

6.4
Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written
instrument signed by the Company and the Investor holding a majority of the Shares at the time of the waiver or amendment. No
waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such
right. No consideration shall be offered or paid to any Investor to amend or consent to a waiver or modification of any provision
of any Transaction Document unless the same consideration is also offered to all Investor who then hold Shares.

 

 6.5 Termination.
This Agreement may be terminated prior to Closing:

 

(a) by
written agreement of the Investor and the Company, a copy of which shall be provided to the Company NY Counsel; and

 

(b) by
the Company or the Investor (as to itself but no other Investor) upon written notice to the other, with a copy to the Company
NY Counsel, if the Closing shall not have taken place by 6:30 p.m. Eastern time on the Outside Date; provided, that the right
to terminate this Agreement under this Section 6.5(b) shall not be available to any Person whose failure to comply with its obligations
under this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time.

 

In
the event of a termination pursuant to Section 6.5(a) or 6.5(b), the Investor shall have the right to a return of up to its entire
Investment Amount deposited with the Company pursuant to Section 2.2(c), without interest or deduction. The Company covenants
and agrees to cooperate with such Investor in obtaining the return of its Investment Amount.

 

In
the event of a termination pursuant to this Section 6.5, the Company shall promptly notify all non-terminating Investor. Upon
a termination in accordance with this Section 6.5, the Company and the terminating Investor shall not have any further obligation
or liability (including as arising from such termination) to the other and no Investor will have any liability to any other Investor
under the Transaction Documents as a result therefrom.

 

6.6
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

    24

     

    

 

6.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Investor. Any Investor may assign any or all of its rights under this Agreement to any Person to whom such Investor
assigns or transfers any Shares, provided such transferee agrees in writing to be bound, with respect to the transferred Shares,
by the provisions hereof that apply to the “Investor.” Notwithstanding the foregoing, the Company may assign its rights
and delegate its duties hereunder regarding the purchase and sale contemplated by Article 2 to any of its Subsidiaries, in which
case (a) the obligation in Section 2.2(c) to deliver such Investor’s Investment Amount in American Dollars may be replaced
by an obligation to deliver such Investment Amount in Chinese Yuan calculated at the prevailing Bank of China exchange rate on
the date of this Agreement to the Subsidiary or any account designated by the Subsidiary, and (b) the rights and duties of the
Company hereunder will, solely with respect to such Investor, in addition to delivering that number of Shares as shall equal the
Investment Amount for such Investor divided by the Per Share Purchase Price to such Investor, include the further obligation (which
shall automatically be assigned or delegated (as the case may be) to, the Subsidiary together with the right to receive such Investment
Amount as described in clause (a) above) to register such capital investment represented by the Investment Amount but without
adjusting or reallocating any of the Subsidiary’s ownership rights, including to distributions of profits or in dissolution.
Any such assignment by the Company shall not relieve it of any obligations hereunder.

 

6.8
No Third-Party Beneficiaries. Except as otherwise contemplated by Section 6.7, this Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.6 (as to the Investor Party).

 

6.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto
hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of the any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim
that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has been commenced in
an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement
or the transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of a Transaction
Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

 

    25

     

    

 

6.10
Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and the
delivery of the Shares.

 

6.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.

 

6.12
Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and
the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

 

6.13
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) the Transaction Documents, whenever any Investor exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Investor
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.

 

6.14
Replacement of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement
Shares. If a replacement certificate or instrument evidencing any Shares is requested due to a mutilation thereof, the Company
may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

6.15
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Investor and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described
in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.

 

    26

     

    

 

6.16
Payment Set Aside. To the extent that the Company makes a payment or payments to any Investor pursuant to any Transaction
Document or an Investor enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

6.17
Independent Nature of Investor’s Obligations and Rights. The obligations of the Investor under any Transaction Document
are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the
performance of the obligations of any other Investor under any Transaction Document. The decision of the Investor to purchase
Shares pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained
herein or in any Transaction Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the
Investor as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investor
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. The Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its
investment hereunder and that no Investor will be acting as agent of such Investor in connection with monitoring its investment
in the Shares or enforcing its rights under the Transaction Documents. The Investor shall be entitled to independently protect
and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such
purpose. The Company acknowledges that each of the Investor has been provided with the same Transaction Documents for the purpose
of closing a transaction with multiple Investor and not because it was required or requested to do so by any Investor.

 

6.18
Limitation of Liability. Notwithstanding anything herein to the contrary, the Company acknowledges and agrees that
the liability of an Investor arising directly or indirectly, under any Transaction Document of any and every nature
whatsoever shall be satisfied solely out of the assets of such Investor, and that no trustee, officer, other investment
vehicle or any other Affiliate of such Investor or any investor, shareholder or holder of shares of beneficial interest of
such a Investor shall be personally liable for any liabilities of such Investor.

 

[THE
REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

[SIGNATURE PAGES TO FOLLOW]

  

    27

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	QHY GROUP	 
	 	 	 
	By:	/s/ Mao
    Xu	 
	Name:	Mao Xu	 
	Title:	President, Chief Executive Officer	 
	 	 	 
	INVESTOR	 
	 	 	 
	 	/s/ Hou Zhigang	 
	Name:	Hou Zhigang IMO	 
	Title:	 	 

 

    28Exhibit 10.2

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2018 (the “date of this Agreement”),
by and among QHY Group, a Nevada corporation (the “Company”), and the investor whose name is set forth on the signature
page hereto (the “Investor”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to exemptions from registration under the Securities
Act (as defined below), the Company desires to issue and sell to the Investor, and the Investor desires to purchase from the Company,
shares of the Company’s Common Stock (as defined below), as more fully described in this Agreement.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

 

ARTICLE
1.

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Section 1.1:

 

“Action”
as to any Person, means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a
deposition) or investigation pending or threatened in writing against or affecting such Person, any of such Person’s Subsidiaries
or any of such Person’s or such Subsidiaries’ respective properties, before or by any court, arbitrator, governmental or administrative
agency, regulatory authority (federal, state, county, local or foreign), stock market, stock exchange or trading facility.

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is
under common control with a Person, as such terms are used in and construed under Rule 144.

 

“Agreement” has the meaning set forth in the preamble to this Agreement.

 

“Available
Undersubscription Amount” has the meaning set forth in Section 4.11(c).

 

“Basic Amount” has the meaning
set forth in Section 4.11(b).

 

“Business
Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions
in the State of New York or State of Nevada are authorized or required by law or other governmental action to close.

 

“Closing”
means the closing of the purchase and sale of the Shares pursuant to Article

 

     

     

    

 

“Closing
Date” means the Business Day on which all of the conditions set forth in Sections 5.1 and 5.2 hereof are satisfied, or
such other date as the parties may agree.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such common stock
may hereafter be reclassified or for which it may be exchanged as a class.

 

“Company”
has the meaning set forth in the recitals to this Agreement.

 

“Company
Deliverables” has the meaning set forth in Section 2.2(a).

 

“Company
Entities” means the Company and all existing Subsidiaries of any such entity and any other entities which hereafter become
Subsidiaries of any such entity.

 

“Common
Stock Equivalents” means any securities of the Company or any Subsidiary which entitle the holder thereof to acquire
Common Stock at any time, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument
that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or
other securities that entitle the holder to receive, directly or indirectly, Common Stock.

 

“Company
NY Counsel” means Mandelbaum Salsburg P.C., having an address at 1270 Avenue of the Americas, Suite 1808, New York, NY
10020.

 

“Disclosure
Materials” has the meaning set forth in Section 3.1(h).

 

“Evaluation
Date” has the meaning set forth in Section 3.1(s).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Existing
Company Entities” means the Company and its respective Subsidiaries.

 

“GAAP” means U.S. generally accepted accounting principles.

 

“Intellectual
Property Rights” has the meaning set forth in Section 3.1(p).

 

“Investment
Amount” means, with respect to the Investor, (USD $xxxxxx).

 

“Investor”
has the meaning set forth in the preamble.

 

“Investor
Deliverables” has the meaning set forth in Section 2.2(b).

 

    2

     

    

 

“Investor
Party” has the meaning set forth in Section 4.6.

 

“Lien”
means any lien, charge, encumbrance, security interest, right of first refusal, right of participation or other restrictions of
any kind.

 

“Losses”
has the meaning set forth in Section 4.6.

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material and adverse effect on the results of operations, assets, properties, prospects, business or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material and adverse impairment to
the Company’s ability to perform on a timely basis its obligations under any Transaction Document.

 

“Money
Laundering Laws” has the meaning set forth in Section 3.1(ee).

 

“New
York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Notice
of Acceptance” has the meaning set forth in Section 4.11(c).

 

“Offer” has the meaning set forth in Section 4.11(b).

 

“Offer
Notice” has the meaning set forth in Section 4.11(b).

 

“Offer
Period” has the meaning set forth in Section 4.11(c).

 

“Offered
Securities” has the meaning set forth in Section 4.11(b).

 

“OFAC” has the meaning set forth in Section 3.1(dd).

 

“Outside
Date” means the fifteenth calendar day (if such calendar day is a Trading Day and if not, then the first Trading Day
following such fifteenth calendar day) following the date of this Agreement.

 

“Per
Share Purchase Price” equals 0.31 USD per Share, and at the price, the Company shall offer, and the Investor shall subscribe
xxxxxx Offered Securities of the Company.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

    3

     

    

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or, to the knowledge of the Company, threatened.

 

“Refused
Securities” has the meaning set forth in Section 4.11(d).

 

“Registrable
Securities” shall mean the Shares.

 

“Responding
Investor” has the meaning set forth in Section 4.11(a).

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC
Reports” has the meaning set forth in Section 3.1(h).

 

“Securities Act” means the Securities Act of 1933,
as amended.

 

“Shares”
means the shares of Common Stock being issued and sold to the Investor by the Company hereunder.

 

“Short
Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO
under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps
and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or
foreign regulated brokers.

 

“Subsequent
Placement” has the meaning set forth in Section 4.11(a).

 

“Subsequent Placement Agreement” has the meaning
set forth in Section 4.11(f).

 

“Subsidiary”
of any Person means any “subsidiary” as defined in Rule 1-02(x) of the Regulation S-X promulgated by the Commission
under the Exchange Act of such Person. Notwithstanding anything to the contrary set forth in any Transaction Document, QHY Water
Solutions International Corp (the “QHY Water Solutions”), PBG Water Solutions International Inc. (the “PBG Water
Solutions”) and their respective subsidiaries are each considered a Subsidiary of the Company.

 

“Trading
Day” means (i) a day on which the Common Stock is traded on a Trading Market or (ii) if the Common Stock is not listed
or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink
Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event
that the Common Stock is not listed or quoted as set forth in (i) or (ii) hereof, then Trading Day shall mean a Business Day.

 

    4

     

    

 

“Trading
Market” means whichever of the New York Stock Exchange, NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global
Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date
in question.

 

“Transaction
Documents” means this Agreement and any other documents or agreements executed in connection with the transactions contemplated
hereunder.

 

“Transfer
Agent” means Globex Transfer, LLC, the current transfer agent of the Company with a mailing address of 780 Deltona Blvd.,
Suite 202, Deltona, FL 32725 and a facsimile number of (813) 344-4490, and any successor transfer agent of the Company.

 

“Trigger
Date” has the meaning set forth in Section 4.11(a).

 

“Undersubscription Amount” has the meaning set forth
in Section 4.11(a).

 

ARTICLE
2.

PURCHASE
AND SALE

 

2.1 Closing. Subject
to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and sell to the Investor, and
the Investor shall purchase from the Company, the Shares representing such Investor’s Investment Amount, calculated as
the quotient of such Investor’s Investment Amount divided by the Per Share Purchase Price. The Closing shall take
place at the offices of Mandelbaum Salsburg P.C. on the Closing Date or at such other location or time as the parties may
agree.

 

2.2
Closing Deliveries. (a) At the Closing, the Company shall deliver or cause to be delivered to the Investor the
following (the “Company Deliverables”):

 

(i) a
single certificate, dated the Closing Date, issued to the Investor, respectively, representing that number of aggregate Shares
to be issued and sold at Closing to such Investor, determined under Section 2.1, registered in the name of such Investor;

 

(ii) the
legal opinion of Company NY Counsel, in agreed form, addressed to the Investor;

 

(b) By
the Closing, the Investor shall deliver or cause to be delivered the agreements specified in Section 5.2(d), each duly signed
by such Investor (collectively, the “Investor Deliverables”).

 

(c) Within
two (2) Trading Days following the date of this Agreement, the Investor shall deliver in accordance with Section 6.7(b) for deposit
and disbursement its Investment Amount, in American Dollars or Chinese Yuan and in immediately available funds, by wire transfer
to an account designated in writing by the Company for such purpose.

 

    5

     

    

 

ARTICLE
3.

REPRESENTATIONS
AND WARRANTIES

 

3.1 Representations
and Warranties of the Company. The Company hereby makes the following representations and warranties to the Investor:

 

(a)
Subsidiaries. None of the Existing Company Entities have any direct or indirect Subsidiaries other than as disclosed in
Schedule 3.1(a) hereto. Except as disclosed in Schedule 3.1(a) hereto, (i) the Company owns, directly or indirectly, all of the
capital stock of each other Existing Company Entity, and each other Existing Company Entity alone or together with other Existing
Company Entities owns, directly or indirectly, all of the capital stock of its respective Subsidiaries, in each case free and
clear of any and all Liens, and (ii) all the issued and outstanding shares of capital stock of each Existing Company Entity and
each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights.

 

(b)
Organization and Oualification. Each Existing Company Entity is duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite
power and authority to own and use its respective properties and assets and to carry on its respective business as currently conducted.
No Existing Company Entity is in violation of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each Existing Company Entity is duly qualified to conduct its respective
businesses and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect.

 

(c)
Authorization; Enforcement. Each Existing Company Entity which is or is to become party to any Transaction Document has
the requisite corporate and other power and authority to enter into and to consummate the transactions contemplated by each such
Transaction Document to which it is a party and otherwise to carry out its obligations thereunder. The execution and delivery
of the Transaction Documents by each Existing Company Entity to be party thereto and the consummation by each of them of the transactions
contemplated thereby have been duly authorized by all necessary action on the part of such Existing Company Entity, and no further
action is required by any of them in connection with such authorization. Each Transaction Document has been (or upon delivery
will have been) duly executed by the Company and each other Existing Company Entity required to execute the same and each Subsidiary
(to the extent any of them is a party thereto) and, when delivered in accordance with the terms hereof, will constitute the valid
and binding obligation of the Company, such Existing Company Entity, and such Subsidiary, enforceable against the Company, the
Existing Company Entity, and the Subsidiary, as the case may be, each in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting
generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

    6

     

    

 

(d)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company, and each other Existing
Company Entity and Subsidiary and the consummation by the Company, and such other Existing Company Entities and Subsidiaries,
of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s,
such Existing Company Entity’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational
or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing an Existing Company Entity
or Subsidiary debt or otherwise) or other understanding to which any Existing Company Entity or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any United States court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(e)
Filings, Consents and Approvals. No Existing Company Entity is required to obtain any consent, waiver, authorization or
order of, give any notice to, or make any filing or registration with, any United States or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the Company, and each Subsidiary,
to the extent such Subsidiary is a party thereto, of the Transaction Documents, other than (i) the filing with the Commission
of one or more Registration Statements, (ii) filings required by state securities laws, (iii) the filing of a Notice of Sale of
Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) the filings required in accordance with
Section 4.5, (v) filings, consents and approvals required by the rules and regulations of the applicable Trading Market, (vi)
those that have been made or obtained prior to the date of this Agreement, and (vii) other post closing securities filings or
notifications required to be made under federal or state securities laws.

 

(f)
Issuance of the Shares. The Shares have been duly authorized and, when issued and paid for in accordance with the Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens. As of the Closing, the
Company has reserved from its duly authorized capital stock the shares of Common Stock issuable pursuant to this Agreement in
order to issue the Shares.

 

    7

     

    

 

(g)
Capitalization. The number of shares and type of all authorized, issued and outstanding capital stock of the Company, and
all shares of Common Stock reserved for issuance under the Company’s various option and incentive plans, is specified in
Schedule 3.1(g). Except as specified in Schedule 3.1(g), no securities of any Existing Company Entity are entitled
to preemptive or similar rights, and no Person has any right of first refusal, preemptive right, right of participation, or any
similar right to participate in the transactions contemplated by the Transaction Documents. Except as specified in Schedule
3.1(g), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to issue additional shares of Common Stock, or securities or rights convertible or exchangeable
into shares of Common Stock. The issue and sale of the Shares hereunder will not, immediately or with the passage of time, obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Investor) and
will not result in a right of any holder of Company or Subsidiary securities to adjust the exercise, conversion, exchange or reset
price under such securities. Except as set forth in Schedule 3.1(g), no Existing Company Entity has issued any capital
stock in a private placement transaction.

 

(h)
SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act
and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof (or
such shorter period as the Company was required by law to file such reports), (the foregoing materials being collectively referred
to herein as the “SEC Reports” and, together with Appendix B hereto and the schedules to this Agreement, the
“Disclosure Materials”) on a timely basis or has timely filed a valid extension of such time of filing and has filed
any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in
all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The financial statements of the Company and each Subsidiary included in the SEC Reports
comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a
consistent basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto,
and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.

 

(i)
Press Releases. To the knowledge of the Company, the press releases disseminated by the Company during the twelve months
preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made and when made, not misleading.

 

Material
Changes. Except as specified on Schedule 3.1(j) or in the Disclosure Materials, since December 31, 2017 (i) there
has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material
Adverse Effect, (ii) no Existing Company Entity has incurred any liabilities (contingent or otherwise) other than (A) trade
payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent with past practice,
and (B) liabilities not in excess of $100,000 in the aggregate not required to be reflected in the Company’s or its
Subsidiaries’ financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission,
(iii) no Existing Company Entity has altered its method of accounting or the identity of its auditors, (iv) no Existing
Company Entity has declared or made any dividend or distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) no Existing Company Entity has
issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.
The Company does not have pending before the Commission any request for confidential treatment of information.

 

    8

     

    

 

(k) Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction
Documents or the Shares or (ii) if there were an unfavorable decision, individually or in the aggregate, result in a loss or liability
in an amount in excess of $10,000 or have or reasonably be expected to result in a Material Adverse Effect. No Existing Company
Entity, nor any director or officer thereof (in his or her capacity as such), is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, except as
specifically disclosed in the SEC Reports. There has not been, and to the knowledge of the Company, there is not pending any investigation
by the Commission involving any Existing Company Entity or any of their respective current or former directors or officers (in
his or her capacity as such). The Commission has not issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(l)
Labor Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any
of the employees of any Existing Company Entity. No Existing Company Entity has any employment or labor contracts, agreements
or other understandings with any Person.

 

(m) Indebtedness:
Compliance. Except as disclosed on Schedule 3.1(m), no Existing Company Entity is a party to any indenture, debt, capital
lease obligations, mortgage, loan or credit agreement by which it or any of its properties is bound. No Existing Company Entity
is (i) in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time
or both, would result in a default by such entity under), nor has any Existing Company Entity received notice of a claim that
it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) in violation of any order of any court, arbitrator or governmental body, or (iii) in violation of any statute, rule or regulation
of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental
protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as
could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. The Company
is in compliance with all effective requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
thereunder that are applicable to it, except where such noncompliance could not have or reasonably be expected to result in a
Material Adverse Effect.

 

    9

     

    

 

(n)
Regulatory Permits. The Existing Company Entities possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC
Reports, except where the failure to possess such permits could not, individually or in the aggregate, have or reasonably be expected
to result in a Material Adverse Effect, and no Existing Company Entity has received any notice of proceedings relating to the
revocation or modification of any such permits.

 

(o)
Title to Assets. There is no real property that is material to the respective businesses of the Existing Company Entities,
except as disclosed in the Disclosure Materials. The Existing Entities have good and marketable title in all personal property
owned by them that is material to their respective businesses, in each case free and clear of all Liens, except for Liens as do
not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of
such property by such Existing Company Entity. Any real property and facilities held under lease by any Existing Company Entity
are held by them under valid, subsisting and enforceable leases of which such Existing Company Entity is in compliance, except
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(p)
Patents and Trademarks. Set forth on Schedule 3.1(p) is a list of patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar rights that the Existing Company Entities own
or have the rights to use (collectively, the “Intellectual Property Rights”). The Intellectual Property Rights constitute
all of the patents, patent applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses
and other similar rights that are necessary and material to the business of the Existing Company Entities in connection with their
respective businesses as described in the Disclosure Materials. No Existing Company Entity has received a written notice that
the Intellectual Property Rights used by any of them violates or infringes upon the rights of any Person. Except as otherwise
disclosed in the Disclosure Materials, to the knowledge of the Existing Company Entities, all such Intellectual Property Rights
are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. To the knowledge
of the Existing Company Entities, no former or current employee, no former or current consultant, and no third-party joint developer
of any Existing Company Entity has any Intellectual Property Rights that are necessary and material to the business of the Existing
Company Entities made, developed, conceived, created or written by the aforesaid employee, consultant or third-party joint developer
during the period of his or her retention by, or joint venture with, such Existing Company Entity which has been asserted against
any Existing Company Entity. The Intellectual Property Rights and the owner thereof or agreement through which they are licensed
to any of the Existing Company Entities are set forth in the Disclosure Materials.

 

(q)
Insurance. Each Existing Company Entity is insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses it is engaged and in the country in which the Existing
Company Entities operate. The Company has no reason to believe that it or any Existing Company Entity will not be able to renew
its existing respective insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business on terms consistent with market for the Company’s and such other Existing Company
Entity’s respective lines of business.

 

    10

     

    

 

(r)
Transactions With Affiliates and Employees; Customers. Except as set forth in the Disclosure Materials, none of the officers,
directors or 5% or more shareholders of any Existing Company Entity, and, to the knowledge of the Company, none of the employees
of any Existing Company Entity, is presently a party to any transaction with any Existing Company Entity (other than for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any
such Person or, to the knowledge of the Company, any entity in which any officer, director, or such employee or 5% or more shareholder
has a substantial interest or is an officer, director, trustee or partner. None of the Existing Company Entities owes any money
or other compensation to any of their respective officers or directors or shareholders, except to extent of contracts and ordinary
course compensation arrangements specified in Schedule 3.1(r). No material customer of any Existing Company Entity has
indicated their intention to diminish their relationship with such Existing Company Entity and no Existing Company Entity has
any knowledge from which it could reasonably conclude that any such customer relationship may be adversely affected.

 

(s)
Internal Accounting Controls. The Existing Company Entities maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization,
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company is establishing disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company Entities and designed such disclosure controls and procedures to ensure that
material information relating to the Company Entities is made known to the certifying officers by others within those entities,
particularly during the period in which the Company’s Form 10-K or 10-Q, as the case may be, is being prepared. The Company’s
certifying officers have evaluated the effectiveness of the Company’s controls and procedures in accordance with Item 307
of Regulation S-K under the Exchange Act for the Company’s most recently ended fiscal quarter or fiscal year-end (such date,
the “Evaluation Date”). The Company presented in its most recently filed Form 10-K or Form 10-Q the conclusions of
the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the
Evaluation Date.

 

(t)
Solvency. Based on the financial condition of the Company, including the Existing Company Entities, as of the Closing Date
(and assuming that the Closing shall have occurred), (i) each Existing Company Entity’s assets do not constitute unreasonably
small capital to carry on their respective business for the current fiscal year as now conducted and as proposed to be conducted
including its capital needs taking into account the particular capital requirements of the business conducted by such Existing
Company Entity, and projected capital requirements and capital availability thereof and (ii) the current cash flow of such Existing
Company Entity, together with the proceeds such Existing Company Entities would receive, were they to liquidate all of their respective
assets, after taking into account all anticipated uses of the cash, would not be sufficient to pay all amounts on or in respect
of its debt when such amounts are required to be paid. The Existing Company Entities intend to incur debts beyond the current
indebtedness so to finance their operation until they generate sufficient revenues.

 

    11

     

    

 

(u)
Certain Fees. Except as described in Schedule 3.1(u), no brokerage or finder’s fees or commissions are or
will be payable by any Existing Company Entity to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by this Agreement. The Investor shall have no obligation
with respect to any fees or with respect to any claims (other than such fees or commissions owed by an Investor pursuant to written
agreements executed by such Investor which fees or commissions shall be the sole responsibility of such Investor) made by or on
behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by this Agreement.

 

(v)
Certain Registration Matters. Assuming the accuracy of the Investor’s representations and warranties set forth in
Sections 3.2(b)-(e), no registration under the Securities Act is required for the offer and sale of the Shares by the Company
to the Investor under the Transaction Documents. The Company is eligible to register its Common Stock for resale by the Investor
under Form S-1 promulgated under the Securities Act. Except as specified in Schedule 3.1(v), no Existing Company Entity
has granted or agreed to grant to any Person other than the Investor any rights (including “piggyback” registration
rights) to have any securities of the Company registered with the Commission or any other governmental authority that have not
been satisfied.

 

(w)
Listing and Maintenance Requirements. Except as specified in the SEC Reports, the Company has not, in the one year preceding
the date hereof, received notice from any Trading Market to the effect that the Company is not in compliance with the listing
or maintenance requirements thereof. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with the listing and maintenance requirements for continued listing of the Common Stock on the Trading Market
on which the Common Stock is currently listed or quoted. The issuance and sale of the Shares under the Transaction Documents does
not contravene the rules and regulations of the Trading Market on which the Common Stock is currently listed or quoted, and no
approval of the stockholders of the Company thereunder is required for the Company to issue and deliver to the Investor the Shares
as contemplated by the Transaction Documents.

 

(x)
Investment Company. The Company is not, and is not an Affiliate of, and immediately following the Closing will not have
become, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

(y)
Application of Takeover Protections. The Company has taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other
similar anti-takeover provision under the Company’s Certificate of Incorporation (or similar charter documents) or the laws
of its state of incorporation that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling
their obligations or exercising their rights under the Transaction Documents, including, without limitation, the Company’s
issuance of the Shares and the Investor’s ownership of the Shares.

 

    12

     

    

 

(z) No
Additional Agreements. No Existing Company Entity has any agreement or understanding with any Investor with respect
to the transactions contemplated by the Transaction Documents other than as specified in the Transaction
Documents.

 

(aa) Consultation
with Auditors. The Company has consulted its independent auditors concerning the accounting treatment of the transactions
contemplated by the Transaction Documents, and in connection therewith has furnished such auditors complete copies of the
Transaction Documents.

 

(bb) Foreign
Corrupt Practices Act. No Existing Company Entity, nor to the knowledge of the Company, any agent or other person
acting on behalf of any Existing Company Entity, has, directly or indirectly, (i) used any funds, or will use any proceeds
from the sale of the Shares, for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign
or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or
to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company or any such Existing Company Entity (or made by any Person acting on their behalf of which
the Company is aware) which is in violation of law, or (iv) has violated in any material respect any provision of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.

 

(cc)
PFIC. The Company is not, and does not intend to become a “passive foreign investment company” within the meaning
of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

(dd) OFAC. No
Existing Company Entity nor, to the knowledge of the Company, any director, officer, agent, employee, Affiliate or Person
acting on behalf of any Existing Company Entity, is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or
indirectly use the proceeds of the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any
Subsidiary, joint venture partner or other Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan,
Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently
subject to any U.S. sanctions administered by OFAC.

 

(ee) Money
Laundering Laws. The operations of each Existing Company Entity are and have been conducted at all times in
compliance with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any applicable governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving any Existing Company Entity with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company, threatened.

 

    13

     

    

 

(ft) Disclosure. Neither
any Company Entity nor any Person acting on its behalf has provided any Investor or its respective agents or counsel with any
information that any Company Entity believes constitutes material, non-public information concerning the Company, the
Subsidiaries or their respective businesses, except insofar as the existence and terms of the proposed
transactions contemplated hereunder may constitute such information. The Company understands and confirms that the Investor
will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All
disclosure provided to the Investor regarding the Company Entities and their respective businesses and the transactions
contemplated hereby, furnished by or on behalf of the Company Entities (including their respective representations and
warranties set forth in this Agreement and the disclosure set forth in any diligence report or business plan provided by any
Company Entity or any Person acting on such Company Entity’s behalf) are true and correct and do not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading.

  

3.2. Representations
and Warranties of the Investor. The Investor hereby, for itself and for no other Investor, represents and warrants to the
Company as follows:

 

(a)
Organization: Authority. Such Investor is an entity duly organized, validly existing and in good standing under the laws
of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents to which it is a party or a signatory and otherwise to carry out its
obligations thereunder. The execution, delivery and performance by such Investor of the transactions contemplated by this Agreement
has been duly authorized by all necessary corporate or, if such Investor is not a corporation, such partnership, limited liability
company or other applicable like action, on the part of such Investor. Each Transaction Document executed by such Investor has
been duly executed by such Investor, and when delivered by such Investor in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Investor, enforceable against it in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general
application.

 

(b)
Investment Intent. Such Investor is acquiring the Shares as principal for its own account and not with a view to or for
distributing or reselling such Shares or any part thereof, without prejudice, however, to such Investor’s right at all times
to sell or otherwise dispose of all or any part of such Shares in compliance with applicable federal and state securities laws.
Subject to the immediately preceding sentence, nothing contained herein shall be deemed a representation or warranty by such Investor
to hold the Shares for any period of time. Such Investor is acquiring the Shares hereunder in the ordinary course of its business.
Such Investor does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Shares.

 

(c)
Investor Status. At the time such Investor was offered the Shares, it is not a registered broker-dealer under Section 15
of the Exchange Act. Such Investor has such experience in business and financial matters that it is capable of evaluating the
merits and risks of an investment in the Shares. Such Investor acknowledges that an investment in the Shares is speculative and
involves a high degree of risk.

 

    14

     

    

 

(d)
General Solicitation. Such Investor is not purchasing the Shares as a result of any advertisement, article, notice, meeting,
or other communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(e)
Access to Information. Such Investor acknowledges that it has reviewed the Disclosure Materials and has been afforded (i)
the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access
to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business,
properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such
additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
an informed investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted by
or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely
on the truth, accuracy and completeness of the Disclosure Materials and the Existing Company Entities’ representations and
warranties contained in the Transaction Documents.

 

(f)
Certain Trading Activities. Such Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with such Investor, engaged in any transactions in the securities of the Company (including, without limitations,
any Short Sales involving the Company’s securities) since the earlier to occur of (1) the time that such Investor was first
contacted by the Company regarding an investment in the Company and (2) the 30th day prior to the date of this Agreement. Such
Investor covenants that neither it nor any Person acting on its behalf or pursuant to any understanding with it will engage in
any transactions in the securities of the Company (including Short Sales) prior to the time that the transactions contemplated
by this Agreement are publicly disclosed.

 

(g)
Independent Investment Decision. Such Investor has independently evaluated the merits of its decision to purchase the Shares
pursuant to the Transaction Documents, and such Investor confirms that it has not relied on the advice of any other Investor’s
business and/or legal counsel in making such decision. Such Investor has not relied on the business or legal advice of any of
its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of such Persons has made
any representations or warranties to such Investor in connection with the transactions contemplated by the Transaction Documents.

 

(h)
Rule 144. Such Investor understands that the Securities must be held indefinitely unless such Securities are registered
under the Securities Act or an exemption from registration is available. Such Investor acknowledges that it is familiar with Rule
144 and that such Investor has been advised that Rule 144 permits resales only under certain circumstances. Such Investor understands
that to the extent that Rule 144 is not available, such Investor will be unable to sell any Securities without either registration
under the Securities Act or the existence of another exemption from such registration requirement.

 

    15

     

    

 

(i)
General. Such Investor understands that the Securities are being offered and sold in reliance on a transactional exemption
from the registration requirements of federal and state securities laws and the Company is relying upon the truth and accuracy
of the representations, warranties, agreements, acknowledgments and understandings of such Investor set forth herein in order
to determine the applicability of such exemptions and the suitability of such Investor to acquire the Securities. Such Investor
understands that no United States federal or state agency or any government or governmental agency has passed upon or made any
recommendation or endorsement of the Securities.

 

The
Existing Company Entities acknowledge and agree that no Investor has made or makes any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in this Section 3.2.

 

ARTICLE
4.

OTHER
AGREEMENTS OF THE PARTIES

 

4.1. Transferability:
Certificate. (a) Shares may only be disposed of in compliance with state and federal securities laws. In connection with any
transfer of the Shares other than pursuant to an effective registration statement, to the Company, to an Affiliate of an Investor
or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to
the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities
Act.

 

(b) Certificates
evidencing Securities will contain the following legend:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

 

The
Company acknowledges and agrees that an Investor may from time to time pledge, and/or grant a security interest in some or
all of the Securities pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required
under the terms of such agreement or account, such Investor may transfer pledged or secured Shares to the pledgees or secured
parties. Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion of legal
counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge but such legal but Such
legal opinion may be required in connection with a subsequent transfer following default by the Investor transferee of the
pledge. No notice shall be required of such pledge. At the appropriate Investor’s expense, the Company will execute and
deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a
pledge or transfer thereof including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of
the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder. Any Securities subject to a pledge or security interest as contemplated by this Section 4.1(b) shall
continue to bear the legend set forth in this Section 4.1(b) and be subject to the restrictions on transfer set forth in
Section 4.1(a).

 

    16

     

    

 

4.2 Furnishing
of Information. As long as any Investor owns any Securities, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the
date hereof pursuant to the Exchange Act. As long as any Investor owns Securities, if the Company is not required to
file reports pursuant to such laws, it will prepare and furnish to the Investor and make publicly available in accordance
with Rule 144(c) such information as is required for the Investor to sell the Securities under Rule 144. The Company further
covenants that it will take such further action as any holder of Securities may reasonably request, all to the extent
required from time to time to enable such Person to sell the Securities without registration under the Securities Act within
the limitation of the exemptions provided by Rule 144.

 

4.3 Integration. The
Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or
solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that
would be integrated with the offer or sale of the Shares in a manner that would require the registration under the
Securities Act of the sale of the Shares to the Investor, or that would be integrated with the offer or sale of the Shares
for purposes of the rules and regulations of any Trading Market in a manner that would require stockholder approval of the
sale of the Shares to the Investor.

 

4.4 Subsequent
Registrations. The Company may not file any registration statement with the Commission with respect to any securities of
the Company prior to the time that all Registrable Shares are registered pursuant to one or more effective Registration
Statement(s), and the prospectuses forming a portion of such Registration Statement(s) is available for the resale of all
Registrable Shares.

 

4.5 Securities
Laws Disclosure: Publicity. By 5:00 p.m. (New York time) on the Trading Day following the Closing Date, (a) the Company
shall issue a press release, disclosing the transactions contemplated by the Transaction Documents and the Closing and (b)
the Company will file a Form 8-K disclosing the material terms of the Transaction Documents (and attach as exhibits
thereto all existing Transaction Documents) and the Closing. The Company covenants that following such disclosure, the
Investor shall no longer be in possession of any material, non-public information with respect to any of the Existing Company
Entities. In addition, the Company will make such other filings and notices in the manner and time required by the Commission
and the Trading Market on which the Common Stock is listed. Notwithstanding the foregoing, the Company shall not publicly
disclose the name of any Investor, or include the name of any Investor in any filing with the Commission (other than the
Registration Statement
and any exhibits to filings made in respect of this transaction in accordance with periodic filing requirements under the Exchange
Act) or any regulatory agency or Trading Market, without the prior written consent of such Investor, except to the extent such
disclosure is required by law or Trading Market regulations.

 

    17

     

    

  

4.6 Indemnification
of Investor. The Company Entities will jointly and severally indemnify and hold the Investor and their
directors, officers, shareholders, partners, employees and agents (each, an “Investor Party”) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation in respect thereof
(collectively, “Losses”) that any such Investor Party may suffer or incur as a result of or relating to any
misrepresentation, breach or inaccuracy of any representation, warranty, covenant or agreement made by any of the Company
Entities in any Transaction Document. In addition to the indemnity contained herein, the Company will reimburse the Investor
Party for its reasonable legal and other expenses (including the cost of any investigation, preparation and travel in
connection therewith) incurred in connection therewith, as such expenses are incurred.

 

4.7 Non-Public
Information. The Company covenants and agrees that neither it, any Company Entity nor any other Person acting on its or
their behalf will provide any Investor or its agents or counsel with any information that the Company believes
constitutes material non-public information, unless prior thereto such Investor shall have executed a written agreement
regarding the confidentiality and use of such information. The Company understands and confirms that the Investor shall be
relying on the foregoing representations in effecting transactions in securities of the Company.

 

4.8 Listing
of Shares. The Company agrees, (i) if the Company applies to have the Common Stock traded on any other Trading Market, it
will include in such application the Shares, and will take such other action as is necessary or desirable to cause the
Shares to be listed on such other Trading Market as promptly as possible, and (ii) the Company will take all action
reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all
material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading
Market.

 

4.9 Use
of Proceeds. The Company will use the net proceeds from the sale of the Shares hereunder for working capital of
the Company and its subsidiaries.

 

4.10 Further
Assurances. The Company will, and will cause all of the Company Entities and their management to, use their best efforts
to satisfy all of the closing conditions under Section 5.1, and will not take any action which could frustrate or delay the
satisfaction of such conditions.

 

    18

     

    

 

4.11 Right
of First Refusal. (a) From the date hereof until the one year anniversary of the Closing Date (plus one additional day
for each Trading Day following the Effective Date of any Registration Statement during which either (1) the Registration
Statement is not effective or (2) the prospectus forming a portion of the Registration Statement is not available for the
resale of all Registrable Securities) (the “Trigger Date”), the Company will not, directly or indirectly, offer,
sell, grant any option to purchase, or otherwise dispose of (or announce any offer, sale, grant or any option to
purchase or other disposition of) any of its equity or equity equivalent securities, including, without limitation, any debt,
preferred stock or other instrument or security that is, at any time during its life and under any circumstances, convertible
into or exchangeable or exercisable for shares of Common Stock or Common Stock Equivalents, or if the Company shall receive
an offer regarding the purchase of the Company’s securities and desires to offer securities consistent with or
otherwise in connection with or in furtherance of such offer (any such offer, sale, grant, disposition or announcement being
referred to as a “Subsequent Placement”) unless the Company shall have first complied with this Section 4.11. If
the Company desires to engage in a Subsequent Placement it shall deliver to each of the Investor a written notice requesting
their written approval to receive nonpublic information regarding the Company. The Investor shall have ten (10) days to
deliver to the Company such approval. Any Investor failing to deliver timely to the Company such written approval, or who
shall have delivered to the Company a written notice withholding such approval, shall be deemed to have waived its rights
under this Section 4.11 with regard to such Subsequent Placement. The Investor who, in response to such request from the
Company, shall have delivered timely to the Company a written approval to receive nonpublic information regarding the Company
(collectively, the “Responding Investor” and each a “Responding Investor”), shall receive a written
notice that the Company desires to engage in a Subsequent Placement specifying the general terms of the offering the Company
desires to make (including, without limitation, all information relating to price, structure and amount of such offering, but
not including the identity of any potential investor therein) and for a period of at least twenty (20) Business Days
after the giving of such notice the Company agrees to negotiate in good faith with the Responding Investor the terms of a
sale of the Company’s securities to the Responding Investor.

 

(b) In
the event that a Subsequent Placement contemplated in the last sentence of Section 4.11(a) shall not have closed by the 30th Business
Day following the delivery to the Responding Investor of the written notice for such Subsequent Placement, and in any event prior
to such Subsequent Placement, the Company shall deliver to the Responding Investor a written notice (the “Offer Notice”)
of any proposed or intended issuance or sale or exchange (the “Offer”) of the securities being offered (the “Offered
Securities”) in a Subsequent Placement, which Offer Notice shall (v) identify and describe the Offered Securities, (x) include
the final form of documents and agreements governing the Subsequent Placement, (y) specify the price and other terms upon which
the Offered Securities are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold
or exchanged, and (z) offer to issue and sell to or exchange with such Investor all of the Offered Securities, allocated among
such Responding Investor (a) based on such Responding Investor’s pro rata portion of the total Investment Amount hereunder attributable
to such Responding Investor (the “Basic Amount”), and (b) with respect to each of the Responding Investor that elects
to purchase its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other Responding
Investor as such Responding Investor shall indicate it will purchase or acquire should the other Responding Investor subscribe
for less than their Basic Amounts (the “Undersubscription Amount”), which process shall be repeated until the Responding
Investor shall have an opportunity to subscribe for any remaining Undersubscription Amount.

 

    19

     

    

 

(c)
To accept an Offer, in whole or in part, such Responding Investor must deliver a written notice to the Company prior to the
end of the fifth Business Day after such Responding Investor’s receipt of the Offer Notice (the “Offer
Period”), setting forth the portion of such Responding Investor’s Basic Amount that such Responding Investor
elects to purchase and, if such Responding Investor shall elect to purchase all of its Basic Amount, the Undersubscription
Amount, if any, that such Responding Investor elects to purchase (in either case, the “Notice of Acceptance”). If
the Basic Amounts subscribed for by all Responding Investor are less than the total of all of the Basic Amounts, then each
Responding Investor who has set forth an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase,
in addition to the Basic Amounts subscribed for, the Undersubscription Amount it has subscribed for; provided,
however, that if the Undersubscription Amounts subscribed for exceed the difference between the total of all the Basic
Amounts and the Basic Amounts subscribed for (the “Available Undersubscription Amount”), each Responding Investor
who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of the Available
Undersubscription Amount as the Basic Amount of such Investor bears to the total Basic Amounts of all Responding Investor
that have subscribed for Undersubscription Amounts, subject to rounding by the Company to the extent its deems
reasonably necessary.

 

(d) The
Company shall have sixty (60) Business Days from the expiration of the Offer Period above to (i) offer, issue, sell or exchange
all or any part of such Offered Securities as to which a Notice of Acceptance has not been given by the Responding Investor (the
“Refused Securities”), but only to the offerees described in the Offer Notice (if so described therein) and only upon
terms and conditions (including, without limitation, unit prices and interest rates) that are not more favorable to the acquiring
person or persons or less favorable to the Company than those set forth in the Offer Notice and (ii) to publicly announce (a)
the execution of such Subsequent Placement Agreement (as defined below), and (b) either (x) the consummation of the transactions
contemplated by such Subsequent Placement Agreement or (y) the termination of such Subsequent Placement Agreement, which shall
be filed with the Commission on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated
therein filed as exhibits thereto. If no disclosure has been made by the Company by the end of the sixty (60) Business Day period
referred to in this subsection (d), the Subsequent Placement shall be deemed to have been abandoned and the Responding Investor
shall no longer be deemed to be in possession of any non-public information with respect to the Company.

 

(e) In
the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the
terms specified in this Section 4.11), then each Responding Investor may, at its sole option and in its sole discretion, reduce
the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than
the number or amount of the Offered Securities that such Responding Investor elected to purchase pursuant to Section 4.11(c) above
multiplied by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually
proposes to issue, sell or exchange (including Offered Securities to be issued or sold to Investor pursuant to Section 4.11(c)
above prior to such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the
event that any Responding Investor so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance,
the Company may not issue, sell or exchange more than the reduced number or amount of the Offered Securities unless and until
such securities have again been offered to the Responding Investor in accordance with Section 4.11(b) above.

 

    20

     

    

 

(f) Upon
the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, the Responding Investor shall
acquire from the Company, and the Company shall issue to the Responding Investor, the number or amount of Offered Securities specified
in the Notices of Acceptance, as reduced pursuant to Section 4.11(e) above if the Responding Investor have so elected, upon the
terms and conditions specified in the Offer. The purchase by the Responding Investor of any Offered Securities is subject in all
cases to the preparation, execution and delivery by the Company and the Responding Investor of a purchase agreement relating to
such Offered Securities substantially the same in form and substance as the agreement disclosed above in Section 4.11(b)(x) and
otherwise reasonably satisfactory to Responding Investor’s counsel (such agreement, the “Subsequent Placement Agreement”).

 

(g) Any
Offered Securities not acquired by the Responding Investor or other persons in accordance with Section 4.11(f) above may not be
issued, sold or exchanged until they are again offered to the Investor under the procedures specified in this Agreement.

 

(h) In
exchange for the Company’s willingness to agree to these procedures, each Responding Investor hereby irrevocably agrees that it
will hold in strict confidence any and all Offer Notices, the information contained therein, and the fact that the Company is
contemplating a Subsequent Placement, until such time as the Company is obligated to make the disclosures required by Section
4.11(d), or unless it notifies the Company in writing that it no longer desires to receive Offer Notices.

 

(i) The
rights contained in this Section 4.11 shall not apply to the issuance and sale by the Company of shares of Common Stock or Common
Stock Equivalents issued as consideration for the acquisition of another company or business in which the shareholders of the
Company do not have an ownership interest, and where the primary purpose is not to raise capital for the Company or Subsidiary,
which acquisition has been approved by the Board of Directors of the Company.

 

ARTICLE
5.

CONDITIONS
PRECEDENT TO CLOSING

 

5.1. Conditions
Precedent to the Obligations of the Investor to Purchase Shares. The obligation of the Investor to acquire Shares at the Closing
is subject to the satisfaction or waiver by such Investor, at or before the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Existing Company Entities contained herein shall
be true and correct in all material respects as of the date when made and as of the Closing as though made on and as of such date;

 

(b)
Performance. The Existing Company Entities shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at
or prior to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents;

 

    21

     

    

 

(d)
Adverse Changes. Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably
could have or result in a Material Adverse Effect or a material adverse change with respect to the Company or the Subsidiaries;

 

(e)
Closing Officer’s Certificate. At the Closing, the Company shall have delivered to the Investor an officer’s
certificate to the effect that each of the conditions specified in Sections 5.1(a) - 5.1(d) is satisfied in all respects;

 

(f)
Company Agreements. The Company shall have delivered or cause to be delivered this Agreement, duly executed by the Company;

 

(g)
Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a); and

 

(h)
Termination. This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

5.2 Conditions
Precedent to the Obligations of the Company to Sell Shares. The obligation of the Company to sell Shares at the Closing is
subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Investor contained herein shall be true and correct
in all material respects as of the date when made and as of the Closing Date as though made on and as of such date;

 

(b)
Performance. The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior
to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents;

 

(d)
Investor Deliverables. The Investor shall have delivered this Agreement; and

 

(e)
Termination. This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

    22

     

    

 

ARTICLE
6.

MISCELLANEOUS

 

6.1
Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of the Transaction Documents. The Company shall pay all stamp and other taxes and duties levied in connection with the sale of
the Shares.

 

6.2
Entire Agreement. The Transaction Documents, together with the Exhibits, Exhibit A and Exhibit B, and Schedules
thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements,
understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.

 

6.3
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via (i) facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the
facsimile number specified in this Section or (ii) electronic mail (i.e., Email) prior to 6:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via (i) facsimile
at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) on a day that is not a Trading Day or
later than 6:30 p.m. (New York City time) on any Trading Day, or (c) the Trading Day following the date of mailing, if sent by
U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required
to be given, if sent by any means other than facsimile or Email transmission. The address for such notices and communications
shall be as follows:

 

	If to the Company: 	QHY Group
	 	1501 Broadway, Suite 1515
	 	New York, NY
	 	Attn.: Mao Xu
	 	 
	With a copy to:	Mandelbaum Salsburg P.C.
	 	1270 Avenue of the Americas, Suite 1808,
	 	New York, NY 10020
	 	Attention: Vincent J. McGill
	 	 
	If to the Investor:	Room 801, unit one, building 10, Guanhuguoji housing estate, No.88 North road of East fourth Ring, Chaoyang District, Beijing City, China 100026
	 	Attention: Mr. Hou Zhigang (IRMO

 

or
such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

    23

     

    

 

6.4
Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written
instrument signed by the Company and the Investor holding a majority of the Shares at the time of the waiver or amendment. No
waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such
right. No consideration shall be offered or paid to any Investor to amend or consent to a waiver or modification of any provision
of any Transaction Document unless the same consideration is also offered to all Investor who then hold Shares.

 

 6.5 Termination.
This Agreement may be terminated prior to Closing:

 

(a) by
written agreement of the Investor and the Company, a copy of which shall be provided to the Company NY Counsel; and

 

(b) by
the Company or the Investor (as to itself but no other Investor) upon written notice to the other, with a copy to the Company
NY Counsel, if the Closing shall not have taken place by 6:30 p.m. Eastern time on the Outside Date; provided, that the right
to terminate this Agreement under this Section 6.5(b) shall not be available to any Person whose failure to comply with its obligations
under this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time.

 

In
the event of a termination pursuant to Section 6.5(a) or 6.5(b), the Investor shall have the right to a return of up to its entire
Investment Amount deposited with the Company pursuant to Section 2.2(c), without interest or deduction. The Company covenants
and agrees to cooperate with such Investor in obtaining the return of its Investment Amount.

 

In
the event of a termination pursuant to this Section 6.5, the Company shall promptly notify all non-terminating Investor. Upon
a termination in accordance with this Section 6.5, the Company and the terminating Investor shall not have any further obligation
or liability (including as arising from such termination) to the other and no Investor will have any liability to any other Investor
under the Transaction Documents as a result therefrom.

 

6.6
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

    24

     

    

 

6.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Investor. Any Investor may assign any or all of its rights under this Agreement to any Person to whom such Investor
assigns or transfers any Shares, provided such transferee agrees in writing to be bound, with respect to the transferred Shares,
by the provisions hereof that apply to the “Investor.” Notwithstanding the foregoing, the Company may assign its rights
and delegate its duties hereunder regarding the purchase and sale contemplated by Article 2 to any of its Subsidiaries, in which
case (a) the obligation in Section 2.2(c) to deliver such Investor’s Investment Amount in American Dollars may be replaced
by an obligation to deliver such Investment Amount in Chinese Yuan calculated at the prevailing Bank of China exchange rate on
the date of this Agreement to the Subsidiary or any account designated by the Subsidiary, and (b) the rights and duties of the
Company hereunder will, solely with respect to such Investor, in addition to delivering that number of Shares as shall equal the
Investment Amount for such Investor divided by the Per Share Purchase Price to such Investor, include the further obligation (which
shall automatically be assigned or delegated (as the case may be) to, the Subsidiary together with the right to receive such Investment
Amount as described in clause (a) above) to register such capital investment represented by the Investment Amount but without
adjusting or reallocating any of the Subsidiary’s ownership rights, including to distributions of profits or in dissolution.
Any such assignment by the Company shall not relieve it of any obligations hereunder.

 

6.8
No Third-Party Beneficiaries. Except as otherwise contemplated by Section 6.7, this Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.6 (as to the Investor Party).

 

6.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto
hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of the any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim
that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has been commenced in
an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement
or the transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of a Transaction
Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

 

    25

     

    

 

6.10
Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and the
delivery of the Shares.

 

6.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.

 

6.12
Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and
the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

 

6.13
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) the Transaction Documents, whenever any Investor exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Investor
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.

 

6.14
Replacement of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement
Shares. If a replacement certificate or instrument evidencing any Shares is requested due to a mutilation thereof, the Company
may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

6.15
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Investor and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described
in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.

 

    26

     

    

 

6.16
Payment Set Aside. To the extent that the Company makes a payment or payments to any Investor pursuant to any Transaction
Document or an Investor enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

6.17
Independent Nature of Investor’s Obligations and Rights. The obligations of the Investor under any Transaction Document
are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the
performance of the obligations of any other Investor under any Transaction Document. The decision of the Investor to purchase
Shares pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained
herein or in any Transaction Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the
Investor as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investor
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. The Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its
investment hereunder and that no Investor will be acting as agent of such Investor in connection with monitoring its investment
in the Shares or enforcing its rights under the Transaction Documents. The Investor shall be entitled to independently protect
and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such
purpose. The Company acknowledges that each of the Investor has been provided with the same Transaction Documents for the purpose
of closing a transaction with multiple Investor and not because it was required or requested to do so by any Investor.

 

6.18
Limitation of Liability. Notwithstanding anything herein to the contrary, the Company acknowledges and agrees that
the liability of an Investor arising directly or indirectly, under any Transaction Document of any and every nature
whatsoever shall be satisfied solely out of the assets of such Investor, and that no trustee, officer, other investment
vehicle or any other Affiliate of such Investor or any investor, shareholder or holder of shares of beneficial interest of
such a Investor shall be personally liable for any liabilities of such Investor.

 

[THE
REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

[SIGNATURE PAGES TO FOLLOW]

  

    27

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	QHY GROUP	 
	 	 	 
	By:	/s/ Mao
    Xu	 
	Name:	Mao Xu	 
	Title:	President, Chief Executive Officer	 
	 	 	 
	INVESTOR	 
	 	 	 
	 	 	 
	Name:	 	 

 

    28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]